Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
- First Posted Date
- 2017-09-06
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT03274011
- Locations
- 🇨🇳
Shanghai Yangpu District East Hospital, Shanghai, Shanghai, China
Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy
Phase 3
- Conditions
- Esophageal Cancer
- Interventions
- Procedure: Discharge the NG tube during the surgery
- First Posted Date
- 2017-09-06
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT03273686
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
Phase 3
Not yet recruiting
- Conditions
- Positive Circumferential Resection MarginEsophageal Squamous Cell Carcinoma
- Interventions
- Radiation: radiation
- First Posted Date
- 2017-09-06
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT03273647
PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS
Phase 2
- Conditions
- Soft Tissue Sarcoma
- Interventions
- Drug: PLD and IFO
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT03268772
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
Not Applicable
Completed
- Conditions
- Oxidative StressPulmonary FunctionInflammationBlood PressureVasoconstrictionCoagulation
- Interventions
- Dietary Supplement: Sunflower seed oil supplementationDietary Supplement: Fish oil supplementation
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 70
- Registration Number
- NCT03255187
- Locations
- 🇨🇳
Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China
Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
Phase 2
Completed
- Conditions
- Advanced Triple-Negative Breast Cancer
- Interventions
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 66
- Registration Number
- NCT03254654
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients
Phase 1
- Conditions
- Triple Negative Breast Cancer
- Interventions
- Combination Product: JS001 120mg+GPCombination Product: GP followed by JS001Combination Product: JS001 240mg+GPCombination Product: JS001 480mg+GP
- First Posted Date
- 2017-08-16
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 31
- Registration Number
- NCT03251313
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery
Not Applicable
- Conditions
- Cancer of Pancreas
- Interventions
- Drug: GEADrug: GADrug: PCIADrug: PCEA
- First Posted Date
- 2017-08-10
- Last Posted Date
- 2019-12-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 540
- Registration Number
- NCT03245346
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
🇨🇳Fudan University Huashan Hospital, Shanghai, Shanghai, China
🇨🇳Fudan University Zhongshan Hospital, Shanghai, Shanghai, China
PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 110
- Registration Number
- NCT03244566
- Locations
- 🇨🇳
Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
🇨🇳National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
🇨🇳Jiangdu people's hospital of Yangzhou, Yangzhou, Jiangsu, China
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Phase 2
Completed
- Conditions
- Endometrial Neoplasm Malignant Stage I
- Interventions
- Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
- First Posted Date
- 2017-08-08
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 64
- Registration Number
- NCT03241914
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath